Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Number of holders
-
404
-
Total 13F shares, excl. options
-
87,035,459
-
Shares change
-
-3,829,915
-
Total reported value, excl. options
-
$7,286,337,875
-
Value change
-
-$311,263,665
-
Put/Call ratio
-
125%
-
Number of buys
-
184
-
Number of sells
-
-154
-
Price
-
$83.72
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q4 2019
472 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q4 2019.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 404 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87,035,459 shares
of 175,611,455 outstanding shares and own 50% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7,163,117 shares), VANGUARD GROUP INC (6,668,053 shares), BAILLIE GIFFORD & CO (5,732,223 shares), JPMORGAN CHASE & CO (5,050,198 shares), WELLINGTON MANAGEMENT GROUP LLP (2,837,915 shares), WADDELL & REED FINANCIAL INC (2,641,148 shares), BANK OF AMERICA CORP /DE/ (2,551,649 shares), ALLIANCEBERNSTEIN L.P. (2,426,571 shares), MACQUARIE GROUP LTD (2,001,711 shares), and ZEVENBERGEN CAPITAL INVESTMENTS LLC (1,600,350 shares).
This table shows the top 404 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.